Sources | Names Used |
---|---|
GDSC1000 | HG-5-88-01 |
PharmacoGx | HG-5-88-01 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CACNA2D1 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.09 |
mRNA | TALDO1 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.09 |
mRNA | SLAMF8 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.09 |
mRNA | LAMTOR1 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.09 |
mRNA | HEATR9 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.09 |
mRNA | CD164L2 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.09 |
mRNA | CHUK | GDSC1000 | pan-cancer | AAC | -0.078 | 0.09 |
mRNA | NR0B2 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.09 |
mRNA | RHOU | GDSC1000 | pan-cancer | AAC | 0.087 | 0.09 |
mRNA | KIAA0430 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.09 |